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Text
During the "golden age of microbiology", the schools of Robert Koch and Louis Pasteur identified pathogenic microorganisms as the causative agents for many communicable human diseases. The Koch's postulates were essential for demonstrating that a specific microbe isolated in pure culture from a lesion of the disease could produce illness in a healthy animal, which gave rise to the concept of pathogenic microbes. These seminal contributions laid the foundation for studying how pathogenic microbes interact with their hosts, a topic that continues to fascinate microbiologists, immunologists, epidemiologists, pathologists, and clinicians alike. Infection and Immunity serves these disciplines by publishing new insights into mechanisms underlying host-pathogen interactions and the development of novel strategies to prevent or treat infectious diseases.
However, more than 100 years after Robert Koch and Louis Pasteur established the microbial etiology of communicable diseases, the field of microbiology is currently experiencing a second period of rapid growth and expansion, driven by the realization that changes in host-associated microbial communities might be at the root of a broad spectrum of non-communicable human diseases. These advances follow on the heels of recent progress in highthroughput sequencing technology, which has provided a wealth of information on the human microbiome and its physiological potential. Initial work in this area established novel links between the gut microbiota, the largest microbial community inhabiting our body, and a wide variety of non-communicable on September 23, 2017 by guest http://iai.asm.org/ Downloaded from 3 diseases, including arthritis (1), arteriosclerosis (2), obesity (3, 4) , diabetes (5), colorectal cancer (6, 7), liver cancer (8), asthma (9, 10) and neurodevelopmental disorders (11), to name just a few. As a result, we are today in the midst of a "renaissance in microbiology", the inclusion of which necessitates an expansion in the scope of Infection and Immunity from our traditional focus on how pathogenic microbes interact with the immune system to embrace a broader view of host microbiota interactions.
The classic concept of pathogenic microbes will continue to be invaluable for studies on the pathogenesis and epidemiology of communicable diseases and also apply to some ailments associated with microbiota disruption. For example, for microbes that fail to cause disease in individuals with intact host defenses, but are associated with illness in individuals with a disrupted microbiota, the traditional concept of opportunistic pathogens or pathobionts might apply. However, the limitations of this theoretical framework become apparent when considering how microbiota-derived metabolites influence human health. For instance, some metabolites generated by the gut-associated microbial community, such as short-chain fatty acids, are important for host nutrition (12) , gut homeostasis (1, 13, 14) and immune development (15) (16) (17) (18) (19) (20) .
Alterations in the community composition or changes in the intestinal environment can alter the metabolite profile generated by the gut microbiota, which in turn can predispose to disease, such as allergic asthma (9, 10) While pioneering work on census taking and predicting physiological potential helped generate a solid foundation for microbiota research, it is now time for a "new bacteriology", aimed at studying microbial physiology and gene regulation in its natural context of a host-associated community (21) . This is an exciting time to be a microbial physiologist, because many of the key observations made by profiling host-associated microbial communities will find an explanation in basic metabolic activities of microbe and host. A good example is gut dysbiosis, an imbalance in the gut-associated microbial community associated with conditions of intestinal inflammation (22). During homeostasis, epithelial hypoxia of the colon (23) helps maintain anaerobiosis thereby ensuring a dominance of obligate anaerobic bacteria within the gut-associated microbial community (24) . Intestinal inflammation is associated with increased epithelial oxygenation (25, 26) , which disrupts anaerobiosis in the colon, thereby driving a shift of bacterial communities from obligate to facultative anaerobes (27) , a microbial signature of gut dysbiosis (22). The shift towards microbial respiration during gut inflammation (28) reflects a metabolic reorientation of host epithelial cells (29) . The colonic epithelium normally consumes oxygen through mitochondrial β-oxidation, which results in hypoxia (23) , while a metabolic reorientation towards anaerobic glycolysis increases epithelial oxygenation (30, on September The near future will likely see many more examples of changes in microbial or host physiology providing a mechanistic explanations for imbalances identified by microbiota profiling or metagenomic analysis. Eventually, this work will give rise to novel preventative or therapeutic strategies for many noncommunicable human diseases. Microbe-host interaction is at the very center of this remarkable development, which is certain to leave its mark on the biomedical research enterprise. 
